Pritelivir, sold as Hovilpri, won U.S. approval on October 9, 2026 for one narrow job: clearing mucocutaneous herpes simplex ...

Antiviral drugs commonly used to treat non-severe influenza appeared to have little or no effect on key clinical outcomes, except for baloxavir (Xofluza), according to a systematic review and ...

Antivirals recommended by the Centers for Disease Control and Prevention (CDC) for treating influenza showed little benefit for nonsevere cases in a systematic review and meta-analysis published in ...

Influenza is an acute respiratory disease that causes epidemics and pandemics in the human population of temperate regions. Influenza epidemics occur every year during the winter months, affecting ...

Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, including antiviral drugs and monoclonal antibodies that suppress an ...

Drugs are supposed to help us get rid of disease, or at least alleviate the symptoms of them. It is therefore particularly unfortunate that—on the contrary— drugs can contribute to making us sicker.

Veklury (remdesivir) is a brand-name intravenous (IV) infusion prescribed to treat COVID-19 in certain adults and children. As with other drugs, Veklury can cause side effects, such as nausea and ...

*Important notice: SSRN publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or ...